Cardiovascular Risks Associated with Gender and Aging - PubMed (original) (raw)

Review

Cardiovascular Risks Associated with Gender and Aging

Jennifer L Rodgers et al. J Cardiovasc Dev Dis. 2019.

Abstract

The aging and elderly population are particularly susceptible to cardiovascular disease. Age is an independent risk factor for cardiovascular disease (CVD) in adults, but these risks are compounded by additional factors, including frailty, obesity, and diabetes. These factors are known to complicate and enhance cardiac risk factors that are associated with the onset of advanced age. Sex is another potential risk factor in aging adults, given that older females are reported to be at a greater risk for CVD than age-matched men. However, in both men and women, the risks associated with CVD increase with age, and these correspond to an overall decline in sex hormones, primarily of estrogen and testosterone. Despite this, hormone replacement therapies are largely shown to not improve outcomes in older patients and may also increase the risks of cardiac events in older adults. This review discusses current findings regarding the impacts of age and gender on heart disease.

Keywords: aging; cardiovascular disease; estrogen; gender; testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Similar articles

• Trophic factors in aging. Should older people receive hormonal replacement therapy?
  Villareal DT, Morley JE. Villareal DT, et al. Drugs Aging. 1994 Jun;4(6):492-509. doi: 10.2165/00002512-199404060-00005. Drugs Aging. 1994. PMID: 8075475 Review.
• Update on cardiovascular disease in post-menopausal women.
  Gorodeski GI. Gorodeski GI. Best Pract Res Clin Obstet Gynaecol. 2002 Jun;16(3):329-55. doi: 10.1053/beog.2002.0282. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12099666 Review.
• Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
  Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG, Budoff MJ, Post WS, Michos ED. Zhao D, et al. J Am Coll Cardiol. 2018 Jun 5;71(22):2555-2566. doi: 10.1016/j.jacc.2018.01.083. J Am Coll Cardiol. 2018. PMID: 29852978 Free PMC article.
• Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
  LaRosa JC. LaRosa JC. Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3. doi: 10.1016/s1049-3867(05)80278-6. Womens Health Issues. 1992. PMID: 1617306

Cited by

• Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes.
  Manabe S, Kataoka H, Mochizuki T, Iwadoh K, Ushio Y, Kawachi K, Watanabe K, Watanabe S, Akihisa T, Makabe S, Sato M, Iwasa N, Yoshida R, Sawara Y, Hanafusa N, Tsuchiya K, Nitta K. Manabe S, et al. J Atheroscler Thromb. 2021 May 1;28(5):491-505. doi: 10.5551/jat.57752. Epub 2020 Aug 6. J Atheroscler Thromb. 2021. PMID: 32759541 Free PMC article.
• Linking Myocardial Infarction and Frailty Status at Old Age in Europe: Moderation Effects of Country and Gender.
  Sentandreu-Mañó T, Torres Z, Luján-Arribas C, Tomás JM, González-Cervantes JJ, Marques-Sule E. Sentandreu-Mañó T, et al. J Cardiovasc Dev Dis. 2024 Jun 8;11(6):176. doi: 10.3390/jcdd11060176. J Cardiovasc Dev Dis. 2024. PMID: 38921676 Free PMC article.
• Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  Nowrouzi-Sohrabi P, Soroush N, Tabrizi R, Shabani-Borujeni M, Rezaei S, Jafari F, Hosseini-Bensenjan M, Stricker BH, van Hoek M, Ahmadizar F. Nowrouzi-Sohrabi P, et al. Front Pharmacol. 2021 Mar 29;12:618208. doi: 10.3389/fphar.2021.618208. eCollection 2021. Front Pharmacol. 2021. PMID: 33854433 Free PMC article. Review.
• "You get what you need when you need it": A mixed methods examination of the feasibility and acceptability of a tailored digital tool to promote physical activity among women in midlife.
  Arigo D, Lassiter JM, Baga K, Jackson DA, Lobo AF, Guetterman TC. Arigo D, et al. Digit Health. 2023 Nov 9;9:20552076231210654. doi: 10.1177/20552076231210654. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 37954685 Free PMC article.
• Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic Myocardium.
  Harris DD, Sabe SA, Broadwin M, Xu C, Stone C, Kanuparthy M, Malhotra A, Abid MR, Sellke FW. Harris DD, et al. Bioengineering (Basel). 2024 Jan 28;11(2):125. doi: 10.3390/bioengineering11020125. Bioengineering (Basel). 2024. PMID: 38391611 Free PMC article.

References

1. 1. Curtis A.B., Karki R., Hattoum A., Sharma U.C. Arrhythmias in Patients ≥ 80 Years of Age: Pathophysiology, Management, and Outcomes. J. Am. Coll. Cardiol. 2018;71:2041–2057. doi: 10.1016/j.jacc.2018.03.019. - DOI - PMC - PubMed
2. 1. North B.J., Sinclair D.A. The intersection between aging and cardiovascular disease. Circ. Res. 2012;110:1097–1108. doi: 10.1161/CIRCRESAHA.111.246876. - DOI - PMC - PubMed
3. 1. Yazdanyar A., Newman A.B. The burden of cardiovascular disease in the elderly: Morbidity, mortality, and costs. Clin. Geriatr. Med. 2009;25:563–577. doi: 10.1016/j.cger.2009.07.007. - DOI - PMC - PubMed
4. 1. Garcia M., Mulvagh S.L., Merz C.N., Buring J.E., Manson J.E. Cardiovascular Disease in Women: Clinical Perspectives. Circ. Res. 2016;118:1273–1293. doi: 10.1161/CIRCRESAHA.116.307547. - DOI - PMC - PubMed
5. 1. Keto J., Ventola H., Jokelainen J., Linden K., Keinanen-Kiukaanniemi S., Timonen M., Ylisaukko-Oja T., Auvinen J. Cardiovascular disease risk factors in relation to smoking behaviour and history: A population-based cohort study. Open Heart. 2016;3:e000358. doi: 10.1136/openhrt-2015-000358. - DOI - PMC - PubMed

Publication types

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • MDPI
  • PubMed Central